Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study.
- DOI
- 10.3390/ph19060861
- Published
- 2026 May 29
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph19060861,
title = {Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study.},
author = {Zhou G and Dael N and Verweij S and Balafas S and Mubarik S and Bos J and Pasmooij AMG and van Baarle D and Mol PGM and de Bock GH and Hak E and Lifelines Corona Research Initiative},
year = {2026},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph19060861},
url = {https://doi.org/10.3390/ph19060861}
}RIS
TY - JOUR TI - Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study. AU - Zhou G AU - Dael N AU - Verweij S AU - Balafas S AU - Mubarik S AU - Bos J AU - Pasmooij AMG AU - van Baarle D AU - Mol PGM AU - de Bock GH AU - Hak E AU - Lifelines Corona Research Initiative PY - 2026 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph19060861 UR - https://doi.org/10.3390/ph19060861 ER -
APA
G, Z., N, D., S, V., S, B., S, M., J, B., AMG, P., D, V. B., PGM, M., GH, D. B., E, H., & Initiative, L. C. R. (2026). Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19060861
Source records
- pubmed · retrieved 2026-09-25T02:08:50.294Z